Triatec Plus

Quick links to important sections

Triatec Plus

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Triatec Plus

Quick Facts

Property Description
Active Ingredients Ramipril and Hydrochlorothiazide
Form Oral Tablet
Pharmacological Class Antihypertensive agent (ACE Inhibitor and Thiazide Diuretic)
Common Use Management of High Blood Pressure (Hypertension)
Origin Synthetically derived compounds

What Type of Medicine is Triatec Plus? (Identity and Classification)

Triatec Plus is a fixed-dose combination product specifically classified as an antihypertensive agent used for the chronic management of essential hypertension (high blood pressure) in adults. The medication is presented as an oral tablet and combines two distinct, synthetically derived active ingredients, Ramipril and Hydrochlorothiazide.

This designation signifies that the tablet contains a blend of two separate pharmacological classes, a strategy that is clinically recognized for optimizing patient adherence and achieving more comprehensive blood pressure control than relying on a single agent. The dual-component approach is distinct from monotherapies, such as the original Ramipril product, and offers a synergistic effect by simultaneously addressing both fluid balance and vascular tone. Combining two agents with complementary mechanisms can lead to improved blood pressure control.


Composition and General Purpose (Ramipril and Hydrochlorothiazide)

The unique composition of Triatec Plus hinges on the pairing of Ramipril (the Angiotensin-Converting Enzyme (ACE) Inhibitor) and Hydrochlorothiazide (the Thiazide Diuretic), each contributing a critical, complementary function. The ACE Inhibitor promotes the relaxation and widening of blood vessels, while the Thiazide Diuretic works by assisting the body in removing excess salt (Sodium Chloride) and water through the kidneys, resulting in diuresis.

The general purpose of this specific combination is the reliable and coordinated lowering of high blood pressure. The combination of the two agents is indicated for treating essential hypertension. This confirms that the medication's primary role is the reduction of high pressure and the sustained reduction of mechanical strain on the heart and arteries, providing a foundational approach to controlling arterial hypertension.

What side effects are possible with Triatec Plus?

Possible Side Effects and Safety Information

The safety profile for this medication, a combination of Ramipril (an ACE Inhibitor) and Hydrochlorothiazide (a Thiazide Diuretic), is based strictly on classifications found in official regulatory documents, such as the Summary of Product Characteristics (SmPC) and the FDA Prescribing Information.

Adverse reactions are formally categorized by frequency and the physiological system affected.

Classification System-Organ Classes Affected Examples of Adverse Reactions
Common Nervous System, Vascular, Respiratory Headache, Dizziness, Persistent Cough, Hypotension (Low Blood Pressure)
Uncommon Metabolic, Gastrointestinal, Skin Electrolyte imbalances (e.g., Hyponatremia), Diarrhea, Rash

Serious adverse reactions are explicitly documented in regulatory labeling. These include Angioedema, which is a potentially life-threatening swelling of the face, tongue, or larynx, and rare reports of Hepatic Failure (liver failure) and severe blood disorders like Agranulocytosis.

Safety constraints and contraindications are defined for specific populations and conditions. The medication is contraindicated (should not be used) in patients with a history of ACE inhibitor-related angioedema and in cases of severe renal impairment (kidney dysfunction). Official labeling also mandates that the medication is not to be used during the second and third trimesters of pregnancy due to the risk of fetal toxicity. Furthermore, regulatory notes indicate that effects like low blood pressure are more likely to occur at the initiation of therapy or when the dose is increased.

Overdose and Emergency Response

Overdose and when to seek help

Overdose manifestations documented in regulatory sources for Triatec Plus (Ramipril/Hydrochlorothiazide) are primarily due to exaggerated therapeutic effects. Overdose may present with severe hypotension (a profound drop in blood pressure), fainting (syncope), and severe dizziness. Other documented manifestations include an irregular heartbeat, seizures, nausea, vomiting, and trouble breathing.

Severe life-threatening outcomes are documented to include cardiovascular collapse, shock, acute kidney injury (AKI), and dangerous severe electrolyte imbalances (such as hyperkalemia or hyponatremia). Additionally, acute respiratory toxicity, including acute respiratory distress syndrome (ARDS), has been reported following high-dose intake of the hydrochlorothiazide component.


Mandated Emergency Actions

Emergency Actions Mandated by Regulators Conditions Requiring Urgent Help
Immediate action is required for serious symptoms. Passing out or trouble breathing.
Contact emergency services immediately. Severe hypotension or signs of shock.
Call a poison control center right away otherwise.

Management of overdose is defined as symptomatic and supportive treatment, as no specific antidote is known for this combination product. Supportive measures may include placing the patient in a supine position and using volume expansion with intravenous fluids. Close hospital monitoring is necessary to manage vital signs and correct severe imbalances.

Therapeutic Uses of Triatec Plus

What Triatec Plus Treats: Main Uses and Benefits

The primary therapeutic use of this medication is the long-term, chronic management of essential hypertension (high blood pressure) in adults. The primary therapeutic purpose aligns with clinical guidelines for managing high blood pressure. This medication is commonly used to help with conditions presenting with systemic imbalance related to persistent high blood pressure, which creates noticeable physiological strain over time.


Therapeutic Scope and Core Benefits

This dual-action therapy is applicable across domains where symptom management is appropriate across domains involving both circulatory tension and fluid volume. It is relevant when supportive symptom management is appropriate for conditions requiring two therapeutic categories. The core indications are essential hypertension and management of symptoms related to fluid volume excess. The medication supports patients in easing symptoms that create noticeable physiological strain. This supportive approach contributes to easing the overall symptom load and supports a positive approach to reducing the burden associated with major complications.

“The combination therapy is applied to help maintain a sense of stability when symptoms are more noticeable, assisting with maintaining functional stability during periods of elevated systemic burden.”

Quick Facts

Property Description
Quick Fact: Relief for Systemic imbalance and Physiological strain from high blood pressure
Primary Use Chronic management of Essential Hypertension
Patient Benefit Supportive long-term cardiovascular management

Eligibility and Restrictions for Use

This fixed-dose combination medicine, which contains Ramipril (an ACE inhibitor) and Hydrochlorothiazide (a diuretic), is prescribed only for patients with high blood pressure (hypertension) that is not adequately controlled by the use of either component alone.

Groups That Must NOT Use Triatec Plus (Contraindications)

The medicine is strictly contraindicated for several populations based on official regulatory documents:

  • Patients with a history of angioedema (serious swelling of the face, tongue, or throat) related to previous ACE inhibitor or Angiotensin II Receptor Antagonist (AIIRA) therapy.
  • Patients in the 2nd and 3rd trimester of pregnancy or those who are breastfeeding. The drug must be discontinued immediately if pregnancy is detected.
  • Patients with severe renal impairment (creatinine clearance below 30 mL/min) or severe hepatic impairment (severe liver failure).
  • Those with significant bilateral renal artery stenosis or stenosis in a single functioning kidney.
  • Patients undergoing extracorporeal treatments (such as certain types of dialysis) that may cause severe allergic reactions.
  • Concurrent use with the medicine aliskiren is contraindicated in patients with diabetes mellitus.
  • Concurrent use with sacubitril/valsartan (used for heart failure) is strictly prohibited.

Other Eligibility Restrictions

The medicine is not recommended for use in pediatric patients (under 18 years of age) as safety and efficacy have not been established. Use in patients with clinically relevant electrolyte imbalances is also not advised.

What should I know about interactions with other medicines?

Triatec Plus Interactions with other medicines and products

The official interaction profile of Triatec Plus (Ramipril/Hydrochlorothiazide) is structured around defined regulatory restrictions and documented pharmacological effects.

Interaction-Related Restrictions

  • Contraindicated Combinations: Co-administration is strictly contraindicated with Aliskiren-containing products and Angiotensin Receptor Blockers (ARBs) in patients with conditions like Diabetes Mellitus or Renal Impairment, reflecting a regulatory restriction on Dual RAAS Blockade. The medication is also prohibited for use with Sacubitril/Valsartan. Furthermore, Extracorporeal Treatments involving blood contact with negatively charged surfaces must be avoided due to the risk of severe reactions.

Clinically Significant Interactions

  • Exposure Modification: Co-administration with Lithium is documented to reduce its renal clearance due to the diuretic component, significantly raising the risk of lithium toxicity. Absorption of the Hydrochlorothiazide component is significantly impaired by Cholestyramine and Colestipol resins.
  • Pharmacodynamic Effects: Agents that increase serum potassium, such as Potassium-sparing Diuretics or Potassium Supplements, carry an increased risk of hyperkalemia. Non-Steroidal Anti-Inflammatory Agents (NSAIDs) and COX-2 Inhibitors may reduce the antihypertensive and diuretic efficacy of the combination. Alcohol and Cannabis may potentiate orthostatic hypotension.

Population and Timing Notes

  • In patients with Impaired Liver Function, the metabolism of the Ramipril component may be slowed, potentially leading to increased plasma levels of the parent drug. A timing rule states that the diuretic component should be discontinued 2 to 3 days before initiating the ACE inhibitor component when feasible.

Mechanism of Action

Triatec Plus is a fixed-dose combination of ramipril and hydrochlorothiazide, modulating two distinct physiological pathways.

Ramipril, a prodrug, is converted to its active metabolite, ramiprilat, primarily in the liver. Ramiprilat acts as a competitive inhibitor of Angiotensin-Converting Enzyme (ACE), an enzyme found in vascular endothelium and other tissues. This inhibition blocks the conversion of Angiotensin I to the potent vasoconstrictor, Angiotensin II, within the Renin-Angiotensin-Aldosterone System (RAAS).

The resulting decrease in systemic Angiotensin II concentration leads to reduced stimulation of the Angiotensin II type 1 (AT1) receptor, causing a reduction in arteriolar vasoconstriction and a decrease in aldosterone secretion from the adrenal cortex. Additionally, ACE inhibition curtails the breakdown of the vasodilator peptide bradykinin, leading to its elevated systemic levels. The downstream systemic consequence is a net reduction in peripheral vascular resistance.

Hydrochlorothiazide acts on the distal convoluted tubule of the nephron. It functions as an inhibitor of the sodium-chloride cotransporter (NCC), a transmembrane protein on the apical membrane of the tubular cells. Blocking NCC activity reduces the reabsorption of Na^+ and Cl^- from the tubular lumen. This sustained reduction in Na^+ reabsorption leads to an osmotic shift, increasing water excretion. The systemic effect is a reduction in circulating plasma volume.

Dosage and Administration Information

Triatec Plus is an oral fixed-dose combination tablet taken for the chronic management of high blood pressure. The drug is administered once daily, and instructions emphasize the need to take it at the same time of day, usually in the morning.

Dosing and Administration Protocol

The route of administration is strictly oral. The tablet must be swallowed whole with liquid and should not be chewed or crushed. The medicine may be taken independently of food, meaning it can be administered either before, with, or after meals, as food does not significantly alter its absorption.

Use protocols stipulate that the fixed combination is generally administered only after adequate blood pressure control has not been achieved with ramipril or hydrochlorothiazide monotherapy, or after individual dose titration. The starting dose is the lowest available strength (e.g., Ramipril 2.5 mg / HCTZ 12.5 mg). The dose may be progressively increased, with titration usually occurring at intervals of two to four weeks, to achieve the long-term target dose. The maximum daily dose for the combination is strictly limited to Ramipril 10 mg and Hydrochlorothiazide 25 mg.

Population and Missed Dose Guidelines

Labeling contains specific constraints for certain populations. The combination product is not recommended for use in patients with severe renal impairment (creatinine clearance <30 mL/min). For older adults, the initial doses should be lower and subsequent titration should be more gradual. If a dose is missed, the next scheduled dose should be taken at the regular time; a double dose should not be taken to compensate for the omission.

Recent Clinical Evidence

Research evidence / Overview of studies for Triatec Plus

Evidence for Use in Essential Hypertension

Research has primarily focused on adults with a diagnosis of high blood pressure, specifically those whose blood pressure status was above a defined threshold when taking a single medicine like ramipril or hydrochlorothiazide alone. The core evaluation included short-term Randomized Controlled Trials (RCTs). These studies were designed to compare the fixed combination tablet against the individual components and, in some cases, a non-active pill (placebo).

These trials primarily monitored outcomes related to systemic or functional imbalance, such as measuring the change in Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) from the start of the study. Studies reported that when the combination was observed in the study populations, the resulting different measurements of blood pressure change were noted compared to the groups taking only one of the active components. The findings also describe patterns observed in the studies where a higher proportion of participants met the predetermined blood pressure metrics when receiving the combination product.

Long-Term Studies and Sustained Control

The existing research has explored the durability of blood pressure metrics over various defined time intervals. While the primary comparative trials typically had a limited follow-up duration, some longer, non-comparative extension studies have monitored responses for up to a year. These studies contribute to the broader evidence landscape by showing that sustained blood pressure measurements were observed in the observed populations throughout the study period.

However, the long-term effects are not fully established when it comes to the specific fixed combination's influence on major cardiovascular health events, such as heart attack or stroke. The evidence for the drug classes involved (ACE inhibitors and diuretics) in studies of these hard outcomes has been established in separate research, but dedicated, large-scale RCTs specifically examining the unique long-term effect of the fixed combination over using the separate components remain insufficient.

Key Studies & References Recommendations | Hypertension in adults: diagnosis and management (NICE Guideline NG136)

Frequently Asked Questions (FAQ)

Common questions about Triatec Plus (FAQ)

Q: What is the main difference between Triatec and Triatec Plus?

A: Official documentation describes Triatec Plus as a fixed-dose combination containing two active medicines: Ramipril and Hydrochlorothiazide (a diuretic). The name Triatec is typically used to refer to the monotherapy product, which contains Ramipril only.

Q: Is Triatec Plus used to treat conditions other than high blood pressure?

A: The official indication for the fixed combination product is the management of essential hypertension (high blood pressure). The fixed combination is specifically approved for blood pressure control. Official information for products containing Ramipril monotherapy may describe other indications.

Q: Is it okay to take over-the-counter pain relievers, like ibuprofen, with Triatec Plus?

A: Official product information includes Non-Steroidal Anti-Inflammatory Agents (NSAIDs) in the interaction profile, and ibuprofen belongs to this class. Co-administration of NSAIDs is described as potentially reducing the blood pressure lowering and fluid-reducing effects of the combination medicine.

Q: Does the dry cough side effect eventually go away or lessen?

A: The cough is associated with the Ramipril component (an ACE inhibitor) and is described as a non-productive tickling cough that may persist during treatment. Regulatory guidance suggests that if the medicine is discontinued, the cough may take time to resolve.

Q: Can Triatec Plus affect kidney function?

A: The medicine has restrictions and is not recommended for use in cases of severe renal impairment (severe kidney dysfunction). Because the diuretic component works on the kidneys, monitoring of renal function (kidney tests) and electrolytes is often recommended.

Q: Is this medicine suitable for older adults?

A: Official guidelines state that for older adults, the initial dose should be lower, and any subsequent dose adjustments should be more gradual. Treatment for older adults requires regular medical supervision.

Q: Does taking the medicine at a specific time of day matter?

A: Official instructions advise taking the medication once daily at the same time of day, usually in the morning. This timing is often noted to minimize night-time disruption due to the diuretic component.

Q: Can a patient with liver problems use Triatec Plus?

A: The medicine is strictly contraindicated in patients with severe hepatic impairment (severe liver failure). For patients with mild to moderate liver impairment, the maximum daily dose is often restricted, and treatment should be initiated under close medical supervision.

Q: Can Triatec Plus cause tiredness or fatigue?

A: Regulatory labels for the active components list tiredness (fatigue) and somnolence (drowsiness) as adverse reactions that have been reported. Official labeling notes that effects like low blood pressure are more frequently reported at the start of therapy.

Q: Is it described in official sources as a medication for both short-term and long-term use?

A: The medicine is officially indicated for the chronic management of high blood pressure, which signifies long-term use. Research studies have been described that follow patients and monitor the durability of blood pressure control for periods of up to one year or more.

Q: Is it true that this type of drug is often used for blood pressure that's hard to control?

A: The official indication is for patients whose blood pressure is not adequately controlled by the use of either ramipril or hydrochlorothiazide alone. This describes a clinical scenario where the blood pressure has proven difficult to control with a single medicine.

Q: How quickly does Triatec Plus start to lower blood pressure?

A: While the active components reach maximum concentration in the blood within hours, the full blood pressure-lowering effect may require several weeks of continuous use. The time it takes to see the complete effect is variable among individuals.

Q: Is it normal to feel dizzy or lightheaded when first taking this medication?

A: Dizziness and Hypotension (low blood pressure) are listed as Common adverse reactions. Official regulatory notes indicate that effects like low blood pressure are more frequently reported at the initiation of therapy or when the dose is increased.

Q: What kind of cough is associated with taking medicines like Triatec Plus?

A: Official documents describe the cough associated with the ACE inhibitor component (Ramipril) as typically a non-productive tickling cough. If a persistent cough occurs, it should be discussed with a healthcare professional.

Q: Are there any specific foods or drinks I should avoid while on this treatment?

A: Official warnings advise patients to avoid using salt substitutes or potassium supplements while taking the medicine, unless specifically directed. This is due to the potential risk of developing high potassium levels, which can be affected by the Ramipril component.

Q: Can Triatec Plus be used by patients with diabetes?

A: Official information includes a restriction against use with the drug aliskiren in patients with diabetes mellitus. Furthermore, the Hydrochlorothiazide component may be associated with an increased blood glucose level or inadequate control of diabetes mellitus, which may require careful monitoring.

Q: Are there any known interactions with herbal supplements?

A: Official documentation advises patients to inform their healthcare professional about all medications, supplements, and herbs they are taking. Herbal products that affect blood pressure, such as those that lower it, may have additive effects with this medicine.

Q: Will I need to take this medication for the rest of my life?

A: The medicine is prescribed for the chronic management of high blood pressure. Since high blood pressure is typically a long-term condition requiring continuous control, the need for continued medication is associated with the long-term management requirements of the underlying condition.

Q: Does Triatec Plus cause weight gain or weight loss?

A: The Hydrochlorothiazide component acts as a diuretic, reducing fluid volume. The Ramipril component has been linked to rare reports of weight gain as a non-common adverse reaction in some official regulatory labels.

Q: Can Triatec Plus cause leg or ankle swelling?

A: Peripheral edema (swelling of the hands or feet) is reported as a potential side effect of the medicine or its components. If swelling occurs, patients are generally advised to discuss it with a healthcare professional.

Q: Is it safe to drink alcohol while using Triatec Plus?

A: Official warnings state that alcohol may potentiate the effects of the medicine, leading to a greater drop in blood pressure and increased dizziness or lightheadedness. This effect has been noted more frequently at the start of treatment or following a dose increase.

Q: Is Triatec Plus associated with any sexual side effects?

A: Official adverse reaction listings for the components include reports of erectile dysfunction as an uncommon side effect.

Q: Can this medication affect my mood or cause depression?

A: Adverse reactions reported in official documents for the medicine's components include depression, anxiety, insomnia, and sleep disorders.

Q: Is it necessary to have blood tests done regularly while taking this medicine?

A: Official labeling recommends periodic monitoring of renal function (kidney tests), electrolytes (such as potassium and sodium), and blood cell counts in certain patient populations. Periodic testing is determined by a healthcare professional based on individual factors.

Q: How is Triatec Plus described in official research studies?

A: Clinical research has primarily been described as short-term Randomized Controlled Trials (RCTs) focusing on adults with high blood pressure that was uncontrolled by a single component. These studies monitored changes in Systolic and Diastolic Blood Pressure compared to the individual components.

Q: Does this medicine make you more sensitive to the sun?

A: The Hydrochlorothiazide component may cause patients to become more sensitive to sunlight (photosensitivity). Regulatory advice is to avoid unnecessary sun exposure and use sunblock or wear protective clothing.

Q: What does the term 'combination therapy' mean for this specific drug?

A: 'Combination therapy' for this medicine refers to a single tablet that contains two different active medicines: Ramipril (an ACE inhibitor) and Hydrochlorothiazide (a diuretic). The goal is to achieve simultaneous effects on fluid balance and vascular tone for better blood pressure control.

Q: What are the signs that Triatec Plus might be working for me?

A: The intended effect of the medicine is to reduce high blood pressure, which is typically monitored using a blood pressure device. The reduction may lead to fewer reported symptoms that can be associated with high blood pressure.

Q: Can I drive or operate machinery while taking Triatec Plus?

A: Official labeling advises that this medicine may cause dizziness or visual problems, especially at the start of treatment. Official labeling notes that activities such as driving or operating machinery may need to be avoided until a patient knows how the medicine affects them.

Q: Are there different strengths of Triatec Plus available?

A: Yes. Official documents describe that the combination is available in different strengths containing varying amounts of the two active ingredients. Examples include tablets with Ramipril 2.5 mg / Hydrochlorothiazide 12.5 mg and Ramipril 5 mg / Hydrochlorothiazide 25 mg.

Q: Does Triatec Plus contain lactose or gluten?

A: Official documents often list lactose monohydrate as an excipient (an inactive ingredient) in the tablet composition. Official information regarding excipients should be consulted by patients with specific intolerances, such as lactose intolerance.

Q: What are the specific signs of electrolyte imbalance to look for?

A: Regulatory documents list warning signs of electrolyte imbalance, which may include dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, and an irregular heartbeat (arrhythmia).

Q: How does Triatec Plus affect potassium levels?

A: The diuretic component (hydrochlorothiazide) tends to decrease serum potassium levels. However, the ACE inhibitor component (ramipril) tends to increase serum potassium levels. The combination is designed to balance these two effects, but monitoring of potassium is recommended.

Q: Is it described as a 'first-line' treatment for high blood pressure?

A: Official documents state the medicine is generally administered only after adequate blood pressure control has not been achieved with either ramipril or hydrochlorothiazide monotherapy (first-line agents). This means it is typically used as a second-step or add-on therapy.

Q: What happens if I stop taking Triatec Plus suddenly?

A: Official guidance implies that treatment for high blood pressure is continuous. Cessation of treatment should only occur under the guidance of a healthcare professional. Sudden cessation of treatment for high blood pressure carries the risk of the original condition's return.

Q: Is there a generic version of Triatec Plus described in official documents?

A: While the brand name is used, official documents list the generic components, Ramipril/Hydrochlorothiazide. The combination product is widely available through various generic manufacturers, as indicated by official drug listings.

Q: Does this medicine help protect the heart?

A: The medicine's primary action is to reduce high blood pressure, which, according to the official research overview, reduces mechanical strain on the heart and arteries. Research on the individual components suggests benefits for cardiovascular risk reduction in certain patient populations.

Q: Can I take cold and flu medicine while on Triatec Plus?

A: The regulatory label warns of interactions with Non-Steroidal Anti-Inflammatory Agents (NSAIDs), which are common in cold/flu medicines. Additionally, cold medicines containing stimulants (e.g., decongestants) are advised against as they may raise blood pressure.

Q: Are there any specific concerns for patients who have had a history of gout?

A: The official adverse reaction profile includes reports of gout being aggravated or an increase in blood uric acid (hyperuricemia), which is a risk factor for gout, linked to the hydrochlorothiazide component.

Q: How is the effect of Triatec Plus on blood sugar described?

A: The official adverse reaction profile includes the possibility of blood glucose increased, a decrease in glucose tolerance, and inadequate control of diabetes mellitus.

How should Triatec Plus be stored and disposed of?

Storage and Disposal of Ramipril/Hydrochlorothiazide (Triatec Plus)

Official Storage Requirements

The Ramipril/Hydrochlorothiazide tablets must be stored at controlled room temperature, typically between 15 C and 30 C. It is mandatory to protect the tablets from excessive heat and humidity, and they must be kept from freezing. The medication should remain in the original, tightly closed container until the date of expiration.

Safety and Disposal

All medicines must be stored out of the sight and reach of children. When disposing of unused or expired tablets, do not flush the medicine down the toilet or place it in household trash without preparation. The officially recommended method is to return the product to a drug take-back program or consult a pharmacist for guidance on safe, regulated disposal according to local environmental rules.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Triatec Plus found in:

A-Z Index: